Ovarian cancer can be categorized into distinct histologic subtypes with varying identifiable risk factors, molecular composition, clinical features, and treatment. The global incidence of ovarian cancer subtypes remains limited, especially in low- and middle-income countries (LMICs) without high-quality ...
ovarian cancerglobal incidence trendsage-period-cohortOvarian cancer is the eighth most common cancer in women worldwide and incidence rates vary markedly by world region. This study provides a comprehensive overview of ovarian cancer incidence trends globally, examining the influence of birth cohort ...
Globally, ovarian cancer is the eighth most common cancer in women, accounting for an estimated 3.7% of cases and 4.7% of cancer deaths in 2020. Until the early 2000s, age-standardized incidence was highest in northern Europe and North America, but this trend has changed; incidence is now ...
Using Global Burden of Disease (GBD) 2013 methodology, the GBD Cancer Collaboration investigators estimate mortality, incidence, years lived with
Background:We estimated the global burden of ovarian cancer (OC) in 194 countries and territories between 2007 and 2017. Methods:Data were extracted from the Global Burden of Disease (GBD), Injuries, and Risk Factors 2017 study. Results:Globally, 286126.80 (95% UI=278075.38-295311.41) incident...
The incidence of thyroid cancer is on the rise, and this disease is projected to become the fourth leading type of cancer across the globe. From 1990 to 2013, the global age-standardized incidence rate of thyroid cancer increased by 20%. This global rise in incidence has been attributed to...
Post is pleased to continue this occasional special focus on the worldwide cancer burden. In this issue, we feature a close look at the cancer incidence and mortality rates in Cameroon. The aim of this special feature is to highlight the global cancer burden for various countries of the......
Cancer constitutes a major global public health issue and ranks as the third leading cause of death globally, responsible for one in seven deaths in 2021 [1, 2]. While it predominantly affects older adults, cancer incidence in adolescents and young adults (AYAs) is relatively low, comprising ...
Adopting combination therapies is a significant factor contributing to the growth of the ovarian carcinoma treatment market. Further, R&D fundings are an add-on to the market. Increase in Cases of Uterine Carcinosarcoma Rising prevalence and increase in incidence of uterine cancer across the ...
Focus on adolescents and young adults as a distinct cancer population in the development of cancer control programmes is crucial to improving outcomes. Previous studies have reported on global cancer incidence and mortality patterns of adolescents and young adults.4, 5, 11 One study used incidence ...